There has also been high interest in the treatment of hypothyroidism in older adults, the treatment of thyroid eye disease and the increase of radiofrequency ablation for thyroid nodules to reduce their size by 50% to 97%. We were delighted to speak with our editorial board member Prof. Glenn Braunstein (Cedars-Sinai Medical Center, Los Angeles, CA, USA) around this year’s research highlights in these issues and what to look out for in 2023.
Questions
- What are the key clinical highlights from 2022 in the field of thyroid disorders? (0:14)
- What are the hot topics and latest research you are looking forward to exploring in 2023? (4:46)
Disclosures: Glenn Braunstein is a consultant for GRAIL.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Shanice Allen.
